| pubmed-article:18327586 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C1122962 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:18327586 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:18327586 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18327586 | pubmed:dateCreated | 2008-10-1 | lld:pubmed |
| pubmed-article:18327586 | pubmed:abstractText | Epidermal growth factor receptor-overexpression reported in colorectal cancer, justifies therapeutic use of EGFR-inhibitors. We have recently conducted a phase II study in 57 patients with EGFR-positive advanced colorectal cancer (ACC) who received gefitinib-FOLFOX6 followed by gefitinib-single agent as maintenance. Main biological objective was to assess sEGFR as surrogate marker of tyrosine kinase inhibition and as predictor of response. | lld:pubmed |
| pubmed-article:18327586 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18327586 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18327586 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18327586 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18327586 | pubmed:issn | 1432-0843 | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:SantoroLL | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:MagniEE | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:ChiappaAA | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:BiffiRR | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:de BraudFF | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:SonzogniAA | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:Dell'OrtoPP | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:ZorzinoLL | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:ZampinoM GMG | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:FazioNN | lld:pubmed |
| pubmed-article:18327586 | pubmed:author | pubmed-author:MonfardiniLL | lld:pubmed |
| pubmed-article:18327586 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18327586 | pubmed:volume | 63 | lld:pubmed |
| pubmed-article:18327586 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18327586 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18327586 | pubmed:pagination | 139-48 | lld:pubmed |
| pubmed-article:18327586 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:meshHeading | pubmed-meshheading:18327586... | lld:pubmed |
| pubmed-article:18327586 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18327586 | pubmed:articleTitle | Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib? | lld:pubmed |
| pubmed-article:18327586 | pubmed:affiliation | Department of Medicine, Medical Care Unit, European Institute of Oncology, Milan, Italy. maria.zampino@ieo.it | lld:pubmed |
| pubmed-article:18327586 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18327586 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:18327586 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18327586 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18327586 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18327586 | lld:pubmed |
